C82.07
Follicular lymphoma grade I, spleen
Clinical Classification Guidelines
Medical Intelligence & Overview
Follicular lymphoma is a type of non-Hodgkin lymphoma that originates in the lymphatic system, specifically affecting the follicles—small spaces within lymph nodes where immune cells develop. When this lymphoma is classified as Grade I and involves the spleen, it indicates a slow-growing, less aggressive form of the disease localized in the spleen. This condition is characterized by the abnormal increase of certain white blood cells called B lymphocytes, which tend to form follicle-like clusters. Recognizing the specifics of this diagnosis helps guide optimal management and treatment options. In this overview, we discuss what follicular lymphoma Grade I of the spleen entails, its causes, how it manifests, and general approaches to diagnosis and treatment. It is essential to consult healthcare professionals for personalized medical guidance and treatment planning.
Causes & Symptoms
Clinical Causes: Genetic mutations within B lymphocytes leading to abnormal growth Age-related changes in immune system functioning History of other lymphoid neoplasms Certain inherited genetic predispositions Environment factors, such as exposure to certain chemicals or radiation, although less common
Key Symptoms: Painless swelling of the spleen, which may be felt in the upper left abdomen B symptoms such as fever, night sweats, or unexplained weight loss (less common in early stages) Fatigue or feeling of fullness due to enlarged spleen Frequent infections if immune function is compromised General malaise or loss of appetite
Diagnostic & Treatment
Diagnosis Path: Diagnosing follicular lymphoma of the spleen involves several steps, including: - Physical examination to check for enlarged spleen or lymph nodes - Blood tests to assess blood cell counts and overall health status - Imaging studies such as ultrasound, computed tomography (CT) scans, or positron emission tomography (PET) scans to evaluate spleen size and the extent of disease - Biopsy of lymphatic tissue or spleen tissue to confirm the presence of lymphoma cells and grade the tumor - Bone marrow biopsy may be performed to determine the spread of disease The combination of these diagnostic tools helps doctors determine the precise nature and stage of the lymphoma, essential for effective treatment planning.
Treatment Protocols: The management of follicular lymphoma Grade I involving the spleen depends on various factors, including overall health, extent of the disease, and specific patient circumstances. Typical treatment options include: - Observation or 'watch and wait' approach in asymptomatic cases where the disease progresses slowly - Immunotherapy using monoclonal antibodies (e.g., rituximab) to target abnormal B cells - Chemotherapy regimens aimed at destroying lymphoma cells - Radiation therapy in localized cases or specific symptomatic areas - Spleen removal (splenectomy) might be considered in certain situations, especially if the spleen is significantly enlarged or causing symptoms - Participation in clinical trials exploring newer therapies Regular follow-up and monitoring are integral parts of managing follicular lymphoma, helping to track disease progression or response to treatment.
Clinical Advice & FAQs
Billing Guidance
Is C82.07 a billable ICD-10 code?
Yes, C82.07 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.07?
Clinical documentation must specify the nature of Follicular lymphoma grade I, spleen and any associated comorbidities for accurate reporting.
Cite this Clinical Reference